Video

Limited Distribution and Data Capture

Leigh Ann Bruhn, director of Avalere Health, notes that limited distribution for specialty pharmaceuticals can improve a manufacturer's data capture capabilities.

Leigh Ann Bruhn, director of Avalere Health, notes that limited distribution for specialty pharmaceuticals can improve a manufacturer's data capture capabilities.

Bruhn refers to the results of the study "DIMENSIONS of Specialty Pharmaceuticals: Evolving Trends in Market Access," conducted by Avalere Health and commissioned by Janssen Biotech, Inc and Johnson & Johnson Health Care Systems.

For more information, read "Emerging Trends Affecting Market Access to Specialty Therapies" at http://www.specialtypharmacytimes.com/news/Emerging-Trends-Affecting-Market-Access-to-Specialty-Therapies.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image Credit: shidlovski | stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.